Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
The current Eli Lilly(LLY) stock price is $1,050.48, with a market capitalization of 993.11B. The stock trades at a price-to-earnings (P/E) ratio of 52.53 and offers a dividend yield of 56.5%.
As of 2025-12-17, Eli Lilly(LLY) stock has fluctuated between $1,048.25 and $1,061.28. The current price stands at $1,050.48, placing the stock +0.2% above today's low and -1.0% off the high.
Eli Lilly(LLY) shares are trading with a volume of 1.61M, against a daily average of 3.49M.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,111.99 and a 52-week low of $623.78.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,111.99 and a 52-week low of $623.78.
LLY News
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund l...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund l...
Billionaire With 30 Years of 30% CAGR Gains Dumped Nvidia, Palantir, and Eli Lilly Quick Read Stanley Druckenmiller delivered over 30% average annual returns f...
Analyst ratings
77%
of 31 ratingsMore LLY News
Eli Lilly stock can be a smart addition to a diversified long-term investment portfolio. Eli Lilly (LLY 1.52%) recently announced stellar results from a phase...
Novo Nordisk A/S (NYSE:NVO) stock has plunged around 41% year to date, as per data from Benzinga Pro. Novo Nordisk’s stock was significantly hit when the compa...
Daiwa analyst Narumi Nakagiri upgraded Eli Lilly (LLY) to Buy from Neutral with a $1,230 price target Published first on TheFly – the ultimate source for real-...
Key Points Eli Lilly is leading the market for GLP-1 medications (for weight loss and diabetes). The company overtook early GLP-1 leader Novo Nordisk. Eli Li...
Market context for Eli Lilly Eli Lilly (LLY) has been quietly grinding higher, with the stock up about 4% over the past month and nearly 39% in the past 3 mont...
The stock market still isn’t pricing in Eli Lilly’s (LLY) dominant position in the market for weight-loss drugs, says Bank of America (BAC). Claim 50% Off TipR...
Goldman Sachs raised the firm’s price target on Eli Lilly (LLY) to $1,145 from $951 and keeps a Buy rating on the shares. Claim 50% Off TipRanks Premium and In...